Australian Clinical Labs Ltd Cash Flow Quality Index
Australian Clinical Labs Ltd cash flow quality index. Australian Clinical Labs Ltd (ACL) has a Cash Flow Quality Index of 11.29x as of December 2025. Operating cash flow of AU$62.87 Million exceeds net income of AU$5.57 Million, indicating high earnings quality where cash backs reported profits. Explore ACL operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Australian Clinical Labs Ltd (2019–2025)
Cash flow quality index of Australian Clinical Labs Ltd from 2019 to 2025. Historical Cash Flow Quality Index for Australian Clinical Labs Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Australian Clinical Labs Ltd (ACL) net asset quality to measure how much of total assets are equity-financed.
Australian Clinical Labs Ltd Cash Flow Quality Index by Year (2019–2025)
Australian Clinical Labs Ltd cash flow quality index by year from 2019 to 2025. Year-by-year earnings quality comparison for Australian Clinical Labs Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Australian Clinical Labs Ltd.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 5.64x | AU$182.80 Million | AU$32.43 Million | ▲ +0.0% |
| 2024 | 5.64x | AU$182.80 Million | AU$32.43 Million | ▼ -15.5% |
| 2024 | 6.67x | AU$159.59 Million | AU$23.93 Million | ▲ +0.0% |
| 2023 | 6.67x | AU$159.59 Million | AU$23.93 Million | ▲ +66.6% |
| 2023 | 4.00x | AU$143.68 Million | AU$35.90 Million | ▲ +0.0% |
| 2022 | 4.00x | AU$143.68 Million | AU$35.90 Million | ▲ +151.1% |
| 2022 | 1.59x | AU$284.09 Million | AU$178.24 Million | ▲ +0.0% |
| 2021 | 1.59x | AU$284.09 Million | AU$178.24 Million | ▼ -37.5% |
| 2021 | 2.55x | AU$153.86 Million | AU$60.37 Million | ▲ +0.0% |
| 2020 | 2.55x | AU$153.86 Million | AU$60.37 Million | ▲ +3.3% |
| 2020 | 2.47x | AU$101.74 Million | AU$41.26 Million | ▲ +0.0% |
| 2019 | 2.47x | AU$101.74 Million | AU$41.26 Million | — |